- Reply to J.-F. Chatal et al. Journal of Clinical Oncology. 2012 Information Resource GET IT
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: A randomized, double-blind phase III trial.
Journal of Clinical Oncology.
Times cited: 581
The evolving role of 131I for the treatment of differentiated thyroid carcinoma.
Journal of Nuclear Medicine.
Times cited: 127